ACE2 and COVID-19: Indeed, soluble ACE2 [21], TMPRSS2, and CTSL inhibitors [22, 23] have shown prominent antiviral effects and are potentially applicable in the prevention of SARS-CoV-2 infection and the treatment of COVID-19.